Summary
The effect of tyramine on the isolated vas deferens of rats was investigated. Tyramine induced a dose-dependent contraction which was blocked by phentolamine and disappeared in adrenergic denervated tissues. In the presence of an antiserum to neuropeptide Y (NPY), the contraction induced by concentrations of tyramine greater than 10 μM was markedly increased. In addition to inducing the release of 3H-norepinephrine (NE), tyramine evoked a concentration-dependent efflux of NPY-like immunoreactivity (NPYLI) from synaptosomal preparations. This action was not modified either by the removal of calcium ion from the medium or by the pretreatment with tetrodotoxin (0.5 μM). Desipramine suppressed the NPY-LI release induced by tyramine apparently by the inhibition of the uptake of tyramine is suggested by the significant positive correlation between the reduction of 4C-tyramine uptake and the inhibition of NPY-LI release induced by desipramine (r = 0.946). Therefore, we suggest that tyramine does induce the release of NPY from rat vas deferens, in addition to effecting NE secretion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bönisch H (1986) The role of co-transported sodium in the effect of indirectly acting amines. Naunyn-Schmiedeberg's Arch Pharmacol 332:135–141
Cheng JT, Shen CL (1986) Tyramine induced release of neuropeptide Y (NPY) in isolated rabbit intestine. Eur J Pharmacol 123:303–306
Dunnet CW (1964) New tables for multiple comparisons with a control. Biometrics 20:482–491
Edvinsoon L, Ekblad E, Hakanson R, Wahlestedt C (1984) Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 83:519–525
Evans MH (1972) Tetrodotoxin, saxitoxin and related substances, their application in neurobiology. Int Rev Neurobiol 15:83–166
Fried G (1981) Small noradrenergic storage vesicles isolated from rat vas deferens-biochemical and morphological characterization. Acta Physiol Scand, Suppl 493:1–28
Fried G, Terenius L, Hökfelt T, Goldstein M (1985) Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens. J Neurosci 5:450–458
Furness JB, Campbell GR, Gillard SM, Malmfors T, Cobb JLS, Burnstock G (1970) Cellular studies of sympathetic denervation produced by 6-hydroxydopamine in the vas deferens. J Pharmacol Exp Ther 174:111–123
Furness JB, Costa M, Emson PC, Hakanson R, Moghimzadeh E, Sundler F, Tayler IL, Chance RE (1983) Distribution, pathways and reactions to drug treatment of nerves to neuropeptide Y and pancreatic polypeptide-like immunoreactivity in the guinea pig digestive tract. Cell Tissue Res 234:71–92
Gray TS, Morley JE (1986) Neuropeptide Y: anatomical distribution and possible funciton in mammalian nervous system. Life Sci 38:389–401
Gregory RA (1982) Regulatory peptides of gut and brain. Br Med Bull 38:219–312
Hertting G, Axelrod J, Patrick RW (1962) Actions of bretylium and guanethidine on the uptake and release of 3H-noradrenaline. Br J Pharmacol 18:161–166
Hökfelt T, Lundberg JM, Lagercrantz H, Tatemoto K, Mutt V, Lindberg J, Terenius L, Everitt BJ, Fuxe K, Agnati L, Goldstein M (1983) Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata. Neurosci Lett 36:217–222
Huidobro-Toro JP, Rohde GC, Tatemoto K (1985) Neuropeptide Y (NPY): an endogenous modulator of the non-adrenergic transmission of the rat vas deferens? Eur J Pharmacol 109: 317–318
Huidobro-Toro JP (1985) Reserpine-induced potentiation of the inhibitory action of neuropeptide Y on the rat vas deferens neurotransmission. Neurosci Lett 59:247–252
Jonsson G (1980) Chemical neurotoxins as denervation tools in neurobiology. Ann Rev Neurosi 3:169–187
Liang NY, Rutledge CO (1982) Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem Pharmacol 31:2479–2484
Lowry OH, Rosebrough NJ, Farr AL, Randell RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Lundberg JM, Terenius L, Hökfelt T, Matling CR, Tatemoto K, Mutt V, Polak JM, Bloom SR, Goldstein M (1982) Neuropeptide Y-like immunoreactivity in peripheral noradrenergic neurons and effectors of NPY on sympathetic function. Acta Physiol Scand 116:477–480
Lundberg JM, Terenius L, Hökfelt T, Goldstein M (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42:167–172
Lundberg JM, Stjärne L (1984) Neuropeptide Y depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation in the rat vas deferens. Acta Physiol Scand 120:477–479
Lundberg JM, Änggård A, Theodorsson-Norheim E, Pernow J (1984) Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation. Neurosci Lett 52:175–180
Lundberg JM, Saria A, France-Cereceda A, Hökfelt T, Terenius L, Goldstein M (1985) Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons. Naunyn-Schmiedeberg's Arch Pharmacol 328:331–340
Okuma Y, Osumi Y (1986) KCl-induced calcium-independent release of endogenous dopamine from rat brain slice. Brain Res 363:47–52
Raiteri M, Del Carmine R, Bertollini A, Levi G (1977) Effect of desmethylimipramine on the release of 3H-norepinephrine induced by various agent in hypothalamic synaptosomes. Mol Pharmacol 13:746–758
Rubin RP (1970) The role of calcium in the release of neurotransmitter substances and hormones. Pharmacol Rev 22:389–428
Starke K, Wagner J, Schümann HJ (1972) Adrenergic neuron blocked by clonidine; comparison with guanethidine and local anesthetics. Arch Int Pharmacodyn 195:291–308
Starke K (1972) Interactions of guanethidine and indirect-acting sympathomimetic amines. Arch Int Pharmacodyn 195:309–314
Swann A, Duman R, Hewitt L (1985) Desipramine binding: relationship to central and sympathetic noradrenergic activity. J Neurochem 44:611–615
Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y — a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (Lond) 296:659–660
Theodorsson-Norheim E, Hemsén A, Lundberg JM (1985) Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extract. Scand J Clin Lab Invest 45:355–365
Vanhoutte PM, Verbeuren TJ, Webb RC (1981) Local modulation of adrenergic neuroeffector interaction in the blood vessel wall. Physiol Rev 61:151–247
Author information
Authors and Affiliations
Additional information
Send offprint request to J. T. Cheng at the above address
Rights and permissions
About this article
Cite this article
Cheng, JT., Shen, C.L. Release of neuropeptide Y (NPY) induced by tyramine in the isolated vas deferens of rat. Naunyn-Schmiedeberg's Arch Pharmacol 335, 255–260 (1987). https://doi.org/10.1007/BF00172793
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00172793